347 related articles for article (PubMed ID: 22188854)
1. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).
Ma H; Parsons MW; Christensen S; Campbell BC; Churilov L; Connelly A; Yan B; Bladin C; Phan T; Barber AP; Read S; Hankey GJ; Markus R; Wijeratne T; Grimley R; Mahant N; Kleinig T; Sturm J; Lee A; Blacker D; Gerraty R; Krause M; Desmond PM; McBride SJ; Carey L; Howells DW; Hsu CY; Davis SM; Donnan GA;
Int J Stroke; 2012 Jan; 7(1):74-80. PubMed ID: 22188854
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
[TBL] [Abstract][Full Text] [Related]
3. European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND.
Amiri H; Bluhmki E; Bendszus M; Eschenfelder CC; Donnan GA; Leys D; Molina C; Ringleb PA; Schellinger PD; Schwab S; Toni D; Wahlgren N; Hacke W
Int J Stroke; 2016 Feb; 11(2):260-7. PubMed ID: 26783318
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
[TBL] [Abstract][Full Text] [Related]
5. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
Picanço MR; Christensen S; Campbell BC; Churilov L; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
[TBL] [Abstract][Full Text] [Related]
6. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
7. Perfusion computed tomography to assist decision making for stroke thrombolysis.
Bivard A; Levi C; Krishnamurthy V; McElduff P; Miteff F; Spratt NJ; Bateman G; Donnan G; Davis S; Parsons M
Brain; 2015 Jul; 138(Pt 7):1919-31. PubMed ID: 25808369
[TBL] [Abstract][Full Text] [Related]
8. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
9. Association of Reperfusion After Thrombolysis With Clinical Outcome Across the 4.5- to 9-Hours and Wake-up Stroke Time Window: A Meta-Analysis of the EXTEND and EPITHET Randomized Clinical Trials.
Campbell BCV; Ma H; Parsons MW; Churilov L; Yassi N; Kleinig TJ; Hsu CY; Dewey HM; Butcher KS; Yan B; Desmond PM; Wijeratne T; Curtze S; Barber PA; De Silva DA; Thijs V; Levi CR; Bladin CF; Sharma G; Bivard A; Donnan GA; Davis SM
JAMA Neurol; 2021 Feb; 78(2):236-240. PubMed ID: 33137171
[TBL] [Abstract][Full Text] [Related]
10. Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study.
Kang DW; Sohn SI; Hong KS; Yu KH; Hwang YH; Han MK; Lee J; Park JM; Cho AH; Kim HJ; Kim DE; Cho YJ; Koo J; Yun SC; Kwon SU; Bae HJ; Kim JS
Stroke; 2012 Dec; 43(12):3278-83. PubMed ID: 23093613
[TBL] [Abstract][Full Text] [Related]
11. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
[TBL] [Abstract][Full Text] [Related]
13. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.
Schellinger PD; Thomalla G; Fiehler J; Köhrmann M; Molina CA; Neumann-Haefelin T; Ribo M; Singer OC; Zaro-Weber O; Sobesky J
Stroke; 2007 Oct; 38(10):2640-5. PubMed ID: 17702961
[TBL] [Abstract][Full Text] [Related]
14. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
[TBL] [Abstract][Full Text] [Related]
15. Treatment with tPA predicts better outcome even if MCA occlusion persists.
Kablau M; Alonso A; Hennerici MG; Fatar M
Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
[TBL] [Abstract][Full Text] [Related]
16. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
[TBL] [Abstract][Full Text] [Related]
17. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
[TBL] [Abstract][Full Text] [Related]
18. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
19. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
20. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
